Relationship between pattern of enhancement and local control of brain metastases after radiosurgery

被引:47
作者
Goodman, KA
Sneed, PK
McDermott, MW
Shiau, CY
Lamborn, KR
Chang, S
Park, E
Wara, WM
Larson, DA
机构
[1] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Neurooncol Serv, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[5] Natl Yang Ming Univ, Vet Gen Hosp Taipei, Ctr Canc, Taipei 112, Taiwan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 50卷 / 01期
关键词
radiosurgery; stereotactic radiosurgery; brain metastases; contrast enhancement; gamma knife;
D O I
10.1016/S0360-3016(00)01584-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: A desired goal in the radiosurgery (RS) of brain metastases is improved Local control. Our earlier retrospective review identified pattern of enhancement on day-of-treatment imaging as a prognostic indicator for freedom from progression (FFP) after RS in 219 brain metastases. The current study was performed to corroborate this preliminary finding. Methods and Materials: Records and imaging studies of patients treated with RS from 1991 to 1997 were reviewed. Each metastasis was categorized as homogeneously-, heterogeneously-, or ring-enhancing. Kaplan-Meier FFP was calculated from the date of RS to the first imaging showing tumor progression. Univariate and multivariate analyses were performed using Cox proportional hazard models stratified by primary site and type of RS (alone, as a boost, or for recurrence). Results: Of 682 lesions in 258 patients, 518 lesions in 193 patients were evaluable. Pattern of enhancement was homogeneous in 59%, heterogeneous in 32%, and ring-like in 8% of lesions. One-year FFP probabilities for homogeneously-, heterogeneously-, and ring-enhancing lesions were 90% (95% confidence interval, 84-93%), 76% (64-84%), and 57% (35-74%), respectively. The p-value for pattern of enhancement from the stratified multivariate analysis was 0.019 adjusting for RS dose and treatment period (1991-1994 vs. 1995-1997), Similar results were achieved adjusting for tumor volume instead of RS dose. Conclusion: Pattern of enhancement is confirmed as a significant prognostic factor for FFP of brain metastases treated with RS, independent of dose and volume. A possible explanation is radioresistance of hypoxic tumor cells associated with necrotic regions, suggesting future investigations with radiosensitizers, hypoxic cell sensitizers, or strategies to improve tumor oxygenation. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 19 条
[1]   A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis [J].
Auchter, RM ;
Lamond, JP ;
Alexander, E ;
Buatti, JM ;
Chappell, R ;
Friedman, WA ;
Kinsella, TJ ;
Levin, AB ;
Noyes, WR ;
Schultz, CJ ;
Loeffler, JS ;
Mehta, MP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (01) :27-35
[2]   Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery [J].
Cho, KH ;
Hall, WA ;
Gerbi, BJ ;
Higgins, PD ;
Bohen, M ;
Clark, HB .
JOURNAL OF NEURO-ONCOLOGY, 1998, 40 (01) :73-86
[3]   A MULTIINSTITUTIONAL EXPERIENCE WITH STEREOTAXIC RADIOSURGERY FOR SOLITARY BRAIN METASTASIS [J].
FLICKINGER, JC ;
KONDZIOLKA, D ;
LUNSFORD, LD ;
COFFEY, RJ ;
GOODMAN, ML ;
SHAW, EG ;
HUDGINS, WR ;
WEINER, R ;
HARSH, GR ;
SNEED, PK ;
LARSON, DA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (04) :797-802
[4]   Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials [J].
Gaspar, L ;
Scott, C ;
Rotman, M ;
Asbell, S ;
Phillips, T ;
Wasserman, T ;
McKenna, WG ;
Byhardt, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04) :745-751
[5]  
Kim YS, 1997, CANCER, V80, P2075, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2075::AID-CNCR6>3.0.CO
[6]  
2-W
[7]   Cancer statistics, 1999 [J].
Landis, SH ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1999, 49 (01) :8-31
[8]  
LANDQUIST C, 1995, SEMIN RADIAT ONCOL, V5, P197
[9]  
Moriarty TM, 1996, RADIOSURG, V1, P83
[10]  
Naoi Y, 1999, Radiat Med, V17, P311